Palantir Aktie

Palantir für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A2QA4J / ISIN: US69608A1088

<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
20.08.2025 09:51:00

Billionaire Stanley Druckenmiller Sold All of His Palantir and Has Piled Into This High-Flying Drug Stock for 4 Consecutive Quarters

Data is the fuel that powers Wall Street. Unfortunately, the amount of data investors have to digest can sometimes be overwhelming. Between earnings season -- the six-week period each quarter where most S&P 500 companies report their operating results -- and near-daily economic data releases, it can be easy for something of importance to go unnoticed.For example, Aug. 14 marked the filing deadline for Form 13Fs with the Securities and Exchange Commission, and it's possible investors may have missed the invaluable information contained within these filings.A 13F is a required filing for institutional investors with at least $100 million in assets under management (AUM). It provides investors with a concise snapshot of which stocks Wall Street's preeminent money managers bought and sold in the latest quarter.Continue readingWeiter zum vollständigen Artikel bei MotleyFool

Analysen zu Palantirmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Palantir 156,72 4,35% Palantir